ReviewFoods (Basel, Switzerland)2026
Cognitive Effects of Taurine and Related Sulphur-Containing Amino Acids: A Systematic Review of Human Trials and Considerations for Plant-Based Dietary Transitions.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
As diets shift towards more plant-based patterns, nutrients mainly supplied by animal-sourced foods are receiving greater attention. Among these are sulphur-containing amino acids (SCAAs) such as taurine, methionine, and cysteine. These compounds play important roles in neuroprotection, antioxidant defence, and cellular signalling; functions that are closely linked to cognitive health. This systematic review examined the effects of SCAA supplementation on cognitive performance in randomised controlled trials (RCTs). Eight RCTs involving 244 healthy participants met the inclusion criteria. All trials focused exclusively on taurine; no studies were found that tested methionine or cysteine. Each used an acute, single-dose design, assessing key cognitive domains and mood outcomes. Overall, acute doses of taurine (typically 1-3 g, up to ~50 mg/kg) produced, at best, small and inconsistent improvements in cognitive function. Most cognitive outcomes showed no effect. Trials that combined taurine with caffeine showed more reliable performance benefits, but they did not isolate taurine's independent effects. Similarly, any positive effects on mood or well-being were minor, inconsistent, and typically observed only under specific conditions, such as when taurine was combined with caffeine, exercise, or sleep deprivation. Importantly, none of the studies measured participants' habitual diets, baseline SCAA status, or specifically recruited individuals with low intake of animal-source foods. This means the cognitive effects of reduced SCAA intake in plant-based diets remain unknown. Current evidence from acute taurine trials provides limited support for short-term benefits to cognition or mood. Longer-term, well-designed studies are urgently needed. These should assess habitual diet and baseline SCAA status and focus on populations with lower animal-derived food intake. Only then can we determine whether lower SCAA availability in plant-based diets represents a nutritional 'green gap' with implications for brain health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.